Fig. 6

The Kaplan–Meier curves for the overall survival rate of metastatic breast cancer patients stratified by the response on ¹⁸F-FLT-PET or ¹⁸F-FDG-PET after one or two cycles of chemotherapy. The metabolic response on post-2c ¹⁸F-FDG-PET based on PERCIST significantly predicted the overall survival rate in these patients